Judd Arnold (CIO of Lake Cornelia): Hunting For Distressed Multi-Baggers

Episode Summary

Executive Summary: The conversation centers on a public-market value investor’s evolving process: prioritize liquid, widely cared-about names with identifiable inflections rather than “too cute” illiquid bargains. He argues energy is unattractive amid bearish OPEC-supply dynamics and price-confirmation signals, while COVID normalization is driving opportunities in autos, pools, and healthcare. Case studies include Leslie’s, AGL, TOI, and Tidewater, with emphasis on leverage, operational turnaround, sponsor alignment, and reflexivity.

Main Topics: Investment process shift: from illiquid cheapness to liquid inflections (Priority: 5/5): The guest explains that going independent expanded his opportunity set but also exposed a mistake pattern: chasing obscure names instead of businesses where others already care and liquidity supports rerating. He now prefers names with catalysts, changing fundamentals, and enough market attention for upside to express. Energy bearishness and price-action discipline (Priority: 5/5): He argues oil and broader energy look unattractive because price action has failed to validate bullish narratives, while supply growth from OPEC, Venezuela, Iran, UAE, and potentially Iraq could pressure prices. He stresses that in liquid macro markets, price is truth and should override spreadsheet certainty. COVID normalization across autos and pools (Priority: 5/5): A major framework is that many post-COVID trades are really normalization stories: pandemic demand surges were met with supply expansion, then demand reversed and margins collapsed. He applies this to used cars, auto finance, rentals, pool-related businesses, and logistics/auction names. Leslie’s as a reflexivity and deleveraging story (Priority: 5/5): Leslie’s is presented as a high-upside leveraged turnaround where operational improvements, better weather, improved comps, seasonal cash generation, and potential refinancing create reflexive equity upside. The guest highlights strong asymmetric payoff if earnings and debt markets cooperate. Healthcare/value-based care reset (Priority: 5/5): He argues healthcare cost trends normalized too low after COVID, breaking value-based care models that had underpriced risk. Now rates are catching up, medical cost trends appear to be stabilizing, and names like AGL and TOI benefit from better contracts, sponsor support, and operating leverage. Setup patience and long-duration inflections (Priority: 4/5): Drawing on distressed investing experience, he emphasizes that the best trades often take years: cheap assets become investable only when a new demand cycle or operating inflection arrives. He cites Tidewater and shipping as examples where patience matters more than near-term certainty.

Key Arguments: Great businesses rarely look cheap when they are investable; investors should seek obvious, liquid names where fundamentals are inflecting. In energy, price action has repeatedly disconfirmed the bullish case, making it dangerous to fight the tape in a highly liquid market. COVID created multi-year distortions in autos, pools, and healthcare; the current opportunity is in normalization rather than pure deep value. Leverage can be beneficial if the business is improving and debt holders can be refinanced or pressured into concessions. Sponsor alignment, competent new management, and better comp plans can materially change outcomes in distressed turnarounds. In healthcare, insurers and value-based care providers are renegotiating toward more realistic medical cost trends and improved contract structures. Reflexivity matters: if a stock rises, financing gets easier and the equity story improves, which can accelerate upside. The best trades often involve buying value and selling growth after a fundamental regime change, not just buying low P/E names. Patience is essential because major inflections often take years to play out and are only obvious in hindsight. His current process favors names with a plausible 50%+ two-year return profile and enough liquidity to matter at size.

Data Points: Energy supply growth scenario: 7-9 million barrels/day - Estimated OPEC/OPEC+ growth over 2-3 years from Venezuela, Iran, UAE, Iraq, and related changes. Global oil base demand: 105-106 million barrels/day - Used as the base for evaluating the scale of prospective supply growth. Used-car age on road: 8 years to 12 years - Average age of cars increased during/after COVID, reflecting people keeping vehicles longer. Used-car price decline: 25% cumulative over three years - Mannheim used-car index fell during the post-COVID normalization period before stabilizing. Lease return rate pre-COVID: ~80% - Ford Motor Credit lease returns were described as stable around this level before COVID. Lease return rate during COVID: ~12% - At the bottom of COVID, most consumers bought out leases rather than returning cars. Lease return rate now: ~50% - The lease return rate has normalized partway back toward pre-COVID levels. Leslie’s term loan: $750 million - Debt load central to the Leslie’s leverage and refinancing discussion. Leslie’s share count: ~10 million shares - Used in valuing equity upside and reflexivity scenarios. Leslie’s peak EBITDA: $275 million - Peak in 2022, cited to show prior earnings power. Leslie’s recent revenue / EBITDA: $1.1 billion revenue / $60 million EBITDA - Last year’s operating performance after normalization and margin compression. Leslie’s 2019 stores: ~950 stores - Store base before pandemic expansion and later rationalization. Leslie’s current/normalized EBITDA potential: ~$175 million - Guest’s estimate of potential rebound after cost cutting and normalization. Leslie’s upside framework: $150/share scenario - Illustrative bull case if EBITDA and valuation multiple recover materially. AGL IPO valuation: $11 billion in 2021 - Reference point for AGL’s former market value before collapse. AGL low-to-current move: ~$8 to $107 - Describes the stock’s massive rebound from distressed levels. AGL member base: ~600,000 Medicare Advantage members - Scale of AGL’s value-based care platform. AGL revenue: $5.5 billion - Revenue base used to argue the equity was mispriced at the lows. AGL starting cash / debt: $370 million cash / $40 million debt - Balance sheet at the start of the year in the turnaround discussion. AGL current rate increase: ~7.5% - CMS baseline rate increase cited as evidence reimbursement is catching up. TOI low entry: ~$0.11-$0.70/share - Range of guest’s initial and larger-sized purchases in Oncology Institute. TOI recent move: $0.11 to north of $5 - Describes the stock’s large multi-bagger move. Tidewater stock move: ~$17 to ~$80 - Example of a longer-duration offshore/shipping inflection working out. Copart/auto ecosystem effect: Higher car return velocity - Fewer leased-car buyouts would increase cars flowing through auctions and logistics.

Pivotal Quotes: "Price is truth." — Guest: Core investing doctrine used to justify respecting oil’s weak price action over bullish macro narratives. "Great businesses almost never look optically cheap." — Guest: Explains why he now prefers liquid names with obvious businesses and catalysts over obscure deep-value ideas. "The number one cure for every slump is finding the next trade and the confidence to know that it’s going to be there." — Guest: Closing reflection on resilience, process, and maintaining forward momentum after losses.

Implications: Listeners should expect a framework focused on post-COVID normalization, leverage plus inflection, and price discipline. Sector-wise, energy looks cautious, while autos, pools, and healthcare offer potential rerating opportunities if operating trends and financing conditions continue improving.